Live Your Vision’s Regeneron Pharmaceuticals REGN Stock Holding History

Live Your Vision’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$235K	Hold	684	–	–	0.07%	66
2018 Q4	$280K	Hold	684	–	–	0.09%	63
2018 Q3	$276K	Hold	684	–	–	0.09%	57
2018 Q2	$250K	Hold	684	–	–	0.08%	60
2018 Q1	$216K	Hold	684	–	–	0.07%	62
2017 Q4	$254K	Hold	684	–	–	0.09%	62
2017 Q3	$306K	Hold	684	–	–	0.11%	59
2017 Q2	$323K	Hold	684	–	–	0.12%	55
2017 Q1	$265K	Buy	684 +294	+75%	+$109K	0.1%	60
2016 Q4	$143K	Hold	390	–	–	0.06%	71
2016 Q3	$157K	Buy	+390	New	+$156K	0.07%	64
2016 Q1	–	Sell	-390	Closed	-$212K	–	65
2015 Q4	$212K	Hold	390	–	–	0.1%	64
2015 Q3	$181K	Buy	+390	New	+$209K	0.09%	68

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Live Your Vision's REGN Position: Q1 2019 in Review

Live Your Vision held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2019 at 684 shares worth $235K. The position accounts for 0.07% of the portfolio, ranked #66.

Live Your Vision first reported a position in REGN in Q3 2015 and has held it in 13 quarters since. The position peaked at $323K in Q2 2017. 718 funds tracked by Wall St. Rank hold REGN as of Q1 2019.

Live Your Vision held 684 shares of Regeneron Pharmaceuticals worth $235K as of Q1 2019.
Live Your Vision left its Regeneron Pharmaceuticals share count unchanged in Q1 2019.
Regeneron Pharmaceuticals made up 0.07% of Live Your Vision's portfolio in Q1 2019, its #66 holding.
Live Your Vision first reported a position in Regeneron Pharmaceuticals in Q3 2015 and has held it in 13 quarters since.
Live Your Vision's Regeneron Pharmaceuticals position peaked at $323K in Q2 2017.
718 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2019.

Based on Live Your Vision's 13F filing for Q1 2019, filed 25 Apr 2019.